 |
Design and conduct of clinical phase-I and -II studies (also in special populations)
as well as phase-III and -IV-studies
|
|
Biopharmaceutical characterization of drug substances and dosage forms
|
|
Imaging studies ("Magnetic Marker Monitoring") to visualize the in-vivo performance
of solid oral preparations (see our PDF-folder)
|
|
Expert statements and scientific consultation as well as advice in strategic drug development
|
In collaboration with affiliate companies and external partners we also offer regulatory affairs
services and to develop concepts for novel dosage forms and their registration, e.g.
preparations with optimized therapeutic properties.
